Ford Motor Co (F) Stock News

State Street Global Advisors & Affiliates disclosed a purchase of 1,673 ordinary shares in DCC plc at €63.50 per share on July 29, 2026, bringing their total holding to 1,217,068 shares representing 1.42474% of the company.

The Portnoy Law Firm has initiated an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) for alleged securities fraud. A former chief transformation officer filed a whistleblower complaint claiming the company misclassified $8-10 million in operational costs as capital expenditures to artificially inflate adjusted EBITDA and boost share price. Following the disclosure on July 8, 2026, Alignment's stock dropped $4.02 per share (16.7%) to $20.03, harming shareholders.

Alphabet delivered a massive earnings beat with $9.11 EPS versus $2.90 expected, becoming the largest contributor to S&P 500 earnings growth for Q2. However, much of the beat ($98 billion) came from unrealized gains on equity holdings, particularly a $94 billion gain on its SpaceX stake following the company's June IPO. Without Alphabet's performance, S&P 500 earnings growth would drop from 37.9% to 25.9%. Alphabet also holds a substantial stake in AI company Anthropic, which could see significant gains when it goes public.

Palantir Technologies has delivered exceptional business results with net income nearly quadrupling to $2.28 billion and Q1 revenue growing 85% year-over-year, yet its stock has fallen 40% from its high of $207.52. The disconnect reflects investor concerns about valuation, with the stock trading at an 80x forward P/E multiple that prices in years of extraordinary growth. The company's Aug. 3 earnings report will test whether growth can sustain at current levels, particularly in the fast-growing U.S. commercial segment which grew 133% year-over-year.

The Vanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 423 holdings, while the Invesco Biotechnology & Genome ETF (PBE) provides focused biotech exposure with 31 holdings and higher growth potential. PBE delivered a stronger 40.88% one-year return but experienced greater volatility with a 37.84% maximum drawdown, while VHT returned 27.85% with lower risk. VHT suits conservative investors seeking steady, low-cost exposure, while PBE appeals to risk-tolerant investors chasing biotech innovation.

Frank Patton and Kimberlee Mott of PacK Financial, managing approximately $150 million in assets, have joined Balmville Wealth Group through LPL Financial's platforms. The advisors, with combined 45 years of experience, were attracted by LPL's enhanced technology, resources, and scalability to support their relationship-driven wealth management practice.

The FDA released briefing materials on July 27, 2026, raising concerns about Capricor Therapeutics' deramiocel cell therapy for treating cardiomyopathy associated with Duchenne muscular dystrophy. The FDA's advisory panel voted 9-3 against the therapy, citing insufficient evidence of effectiveness and concerns that the company changed how it measured trial results. Following the announcement, Capricor's stock price plummeted approximately 67% on July 29, 2026, and fell another 50% in premarket trading on July 30, 2026.

Johnson Fistel, PLLP is investigating whether INNIO N.V. (NASDAQ: INIO) or its executive officers violated securities laws. The investigation was prompted by the company's July 28, 2026 earnings call where CFO Dennis Schulze disclosed that expanded Data Center products were priced with lower margins than core business. Following these disclosures, INNIO shares declined approximately 15% from its $27.00 IPO price to around $23, raising questions about whether the company misrepresented or failed to timely disclose material information to investors.

Johnson Fistel, PLLC is investigating Beta Bionics, Inc. for potential securities law violations related to false or misleading statements about growth trends and new patient starts. The company reported Q4 2025 new patient starts of at least 5,581 (36% YoY growth) on January 8, 2026, which fell below analyst expectations and showed significant deceleration from the prior quarter's 68% growth rate, potentially causing investor losses.

Ferrari is bumping up its 2026 guidance after beating Wall Street's second quarter expectations amid "healthy" demand for its products.

Vericel Corporation reported strong Q2 2026 results with total revenue increasing 22% to $77.5 million and MACI revenue growing 23%. The company raised its full-year 2026 revenue guidance to $330-$340 million and announced a $200 million share repurchase program. Net income reached $2.2 million with free cash flow of $14.3 million, demonstrating sustained profitability and cash generation.

Crescent Biopharma reported Q2 2026 results with continued enrollment in its ASCEND Phase 1/2 trial for CR-001, a PD-1 x VEGF bispecific antibody. The company completed a $143.7 million public offering extending cash runway to H2 2028 and announced multiple clinical data readouts expected beginning Q1 2027. R&D expenses increased to $19.4 million due to expanded clinical activities, while the company maintains strategic partnerships with Kelun-Biotech for development in Greater China.

CSW Industrials reported record fiscal 2027 first quarter results with total revenue of $351 million (up 33%), adjusted EPS of $3.84 (up 35%), and adjusted EBITDA of $102 million (up 48%). The Contractor Solutions segment achieved 6% organic revenue growth for the second consecutive quarter. The company has invested $1 billion in five acquisitions since May 2025, including MARS Parts and Aspen Manufacturing, while maintaining a net leverage ratio of 2.37x within its target range.

Red Cat Holdings' Teal Drones subsidiary secured a $2.49 million firm-fixed-price contract from the U.S. Air Force Security Forces Center to conduct a technical and operational assessment of its Black Widow small unmanned aircraft systems as a potential successor to the current Teal 2 fleet. The contract includes systems, training, batteries, spares and shipping, with delivery expected by August 24, 2026.

Investec Bank plc, acting as Joint Broker to Gamma Communications Plc, disclosed dealings in ordinary shares of Gamma Communications on 29th July 2026. The exempt principal trader purchased and sold 40,642 ordinary shares at prices ranging from 61.5 to 977.596 per unit. The disclosure was filed under Rule 8.5 of the Takeover Code.

Investec Bank plc, acting as Advisor and Broker to Gooch & Housego plc, disclosed public dealing in ordinary shares of Gooch & Housego plc on 29th July 2026. The bank purchased 11,800 shares and sold 15,000 shares at prices ranging between 1220 pence per unit, in compliance with Takeover Code Rule 8.5 disclosure requirements.

Investec Bank plc, acting as Advisor & Joint Broker to Advanced Medical Solutions Group Plc, disclosed public dealing in the company's ordinary shares on 29th July 2026. The bank purchased 419,640 shares at prices between 280.00-280.25 per unit and sold 550,000 shares at 280.00 per unit. The disclosure was made in compliance with Rule 8.5 of the Takeover Code.

Dimensional Fund Advisors Ltd. has disclosed a 1.26% interest in Prologis Inc, comprising 11,785,505 USD 0.01 common shares as of July 29, 2026. The disclosure includes a purchase of 1,241 shares at $145.47 per share and a transfer out of 1,915 shares. Dimensional also made disclosures regarding Segro PLC in relation to the same offer.

Dimensional Fund Advisors Ltd. has disclosed a 1.58% interest in Gamma Communications PLC, holding 1,414,785 ordinary shares as of July 29, 2026. The disclosure was made under Rule 8.3 of the Takeover Code, with the fund also reporting a sale of 1,984 shares at 9.6752 GBP per unit during the disclosure period.

U.S. Treasury yields continued their upward climb on Thursday as investors weighed the Federal Reserve's decision to hold interest rates steady.

eSUN has commercially launched PLA-Coffee, an innovative bio-based 3D printing filament that combines repurposed coffee grounds with biodegradable PLA. The material addresses sustainability demands, reduces carbon footprint, and offers aesthetic advantages including a natural matte finish that conceals layer lines. The filament maintains compatibility with standard FDM 3D printers and is optimized for home decor and desktop applications.

Renault SA filed its 2026 Half-Year Financial Report with French Financial Markets Authority on July 30, 2026. The company reported robust performance with strong revenue growth in H1 2026 driven by both Automotive and other segments, confirmed its full-year 2026 guidance, and is implementing its futuREady strategy. The company also acknowledged an ongoing judicial investigation regarding older-generation Diesel vehicles.

Renault SA has made available its first half 2026 Financial Report to the French financial markets authority on July 30, 2026. The company reports robust performance and strong revenue growth in H1 2026 across both Automotive and other segments, while confirming its full-year 2026 guidance and advancing its futuREady strategic plan. The group also addressed an ongoing judicial investigation from 2017 regarding older-generation diesel vehicles.

Atos Group announced its 2026 Half-Year Financial Report, reporting strong first-half performance with sustained delivery and indicating the company is on track to achieve full-year targets.

A securities class action lawsuit has been filed against Intuit Inc., alleging the company made materially false and misleading statements about its competitive advantages, business model, and TurboTax revenue growth guidance. The lawsuit claims Intuit was losing significant business due to competitive and pricing pressures. Investors who purchased Intuit securities between August 22, 2025 and May 20, 2026 may be entitled to compensation. The lead plaintiff deadline is September 8, 2026.

Rosen Law Firm is reminding investors who purchased Insulet Corporation securities between February 21, 2025 and May 26, 2026 of an important August 31, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Insulet made false and misleading statements regarding defective manufacturing controls and procedures that created a foreseeable risk of product safety violations.

Hagens Berman has opened an investigation into Capricor Therapeutics following a 64% stock collapse on July 27, 2026. The FDA's briefing document revealed that the company's lead drug candidate Deramiocel failed to meet pre-specified primary and secondary efficacy endpoints in the Phase 3 HOPE-3 trial, contradicting Capricor's December 2025 announcement of 'positive' results. The investigation focuses on whether Capricor misled investors about trial efficacy and undisclosed changes to the statistical analysis plan.

Rosen Law Firm is urging investors who purchased or sold Genius Group Limited securities between April 12, 2022 and May 30, 2025 to join a class action lawsuit against Citadel Securities LLC and Virtu Americas LLC. The defendants are accused of engaging in 'spoofing'—submitting and cancelling orders without intent to execute them—to manipulate Genius stock prices and increase transaction costs. The lead plaintiff deadline is August 28, 2026.

A securities class action lawsuit has been filed against BitGo Holdings, Inc. alleging that offering documents and statements made during its January 2026 IPO and through May 2026 contained material misstatements and omissions. Specifically, the lawsuit claims defendants understated risks from declining digital asset prices and made false statements about the company's financial performance and business prospects. Investors who purchased BitGo securities during the class period have until August 7, 2026 to become lead plaintiffs.

Daxor Corporation announced the launch of a new outpatient Blood Volume Analysis (BVA) program at a healthcare facility in eastern Kansas through its turnkey ezBVA Lab send-out model. The service provides 98% accurate blood volume measurements within 24 hours without requiring capital equipment, enabling clinicians to optimize decongestion strategies and reduce hospital readmissions.